CYH vs HCA ᐉ Comparison: Which is Better to Invest?
Loading...
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYH is a Buy and HCA is a Sell.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CYH’s FA Score shows that 1 FA rating(s) are green whileHCA’s FA Score has 2 green FA rating(s).
- CYH’s FA Score: 1 green, 4 red.
- HCA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CYH’s TA Score shows that 3 TA indicator(s) are bullish while HCA’s TA Score has 4 bullish TA indicator(s).
- CYH’s TA Score: 3 bullish, 7 bearish.
- HCA’s TA Score: 4 bullish, 4 bearish.
Price Growth
CYH (@Medical/Nursing Services) experienced а -2.60% price change this week, while HCA (@Medical/Nursing Services) price change was -1.64% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.49%. For the same industry, the average monthly price growth was +4.42%, and the average quarterly price growth was +7.62%.
Reported Earning Dates
CYH is expected to report earnings on Apr 30, 2024.
HCA is expected to report earnings on Apr 26, 2024.
Industries' Descriptions
@Medical/Nursing Services (-3.49% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| CYH | HCA | CYH / HCA | |
| Capitalization | 459M | 88.2B | 1% |
| EBITDA | 1.54B | 12.7B | 12% |
| Gain YTD | -4.153 | 19.437 | -21% |
| P/E Ratio | 2.21 | 17.40 | 13% |
| Revenue | 12.5B | 65B | 19% |
| Total Cash | 38M | 935M | 4% |
| Total Debt | 12.2B | 41.9B | 29% |
CYH | HCA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 13 | |
SMR RATING 1..100 | 100 | 45 | |
PRICE GROWTH RATING 1..100 | 98 | 62 | |
P/E GROWTH RATING 1..100 | 98 | 34 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (4) in the Hospital Or Nursing Management industry is in the same range as CYH (33). This means that HCA’s stock grew similarly to CYH’s over the last 12 months.
HCA's Profit vs Risk Rating (13) in the Hospital Or Nursing Management industry is significantly better than the same rating for CYH (100). This means that HCA’s stock grew significantly faster than CYH’s over the last 12 months.
HCA's SMR Rating (45) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CYH (100). This means that HCA’s stock grew somewhat faster than CYH’s over the last 12 months.
HCA's Price Growth Rating (62) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CYH (98). This means that HCA’s stock grew somewhat faster than CYH’s over the last 12 months.
HCA's P/E Growth Rating (34) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CYH (98). This means that HCA’s stock grew somewhat faster than CYH’s over the last 12 months.
| CYH | HCA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 88% | 2 days ago 57% |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 85% | 2 days ago 48% |
| TrendWeek ODDS (%) | 2 days ago 85% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 70% |
| Advances ODDS (%) | 20 days ago 82% | 20 days ago 69% |
| Declines ODDS (%) | N/A | 2 days ago 55% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 78% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 72% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| QICNX | 13.63 | -0.01 | -0.07% |
| AQR International Multi-Style N | |||
| WPLCX | 13.62 | -0.09 | -0.66% |
| WP Large Cap Income Plus Institutional | |||
| MRERX | 46.68 | -0.58 | -1.23% |
| MFS Core Equity R2 | |||
| JEMNX | 8.96 | -0.13 | -1.43% |
| JHancock Emerging Markets Equity R4 | |||
| STCZX | 13.20 | -0.24 | -1.79% |
| Virtus Silvant Large-Cap Growth Stk R6 | |||
CYH and
Correlation & Price change
A.I.dvisor indicates that over the last year, CYH has been loosely correlated with SGRY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYH jumps, then SGRY could also see price increases.
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been closely correlated with THC. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then THC could also see price increases.